EANS-News

Semperit AG Holding / Successful Start in 2016 - Seite 2

stagnating market. In a difficult market environment, the Semperform
segment profited from the successful integration of the German
profile manufacturer Leeser as well as the increase in market share
in the handrail business.

Revenue of the Industrial Sector rose 6.0% to EUR 133.6 million in
the first quarter of 2016. EBITDA climbed 13.7% to EUR 25.1 million.

Medical Sector: Improved profitability In the Medical Sector
(Sempermed segment), process optimisations and efficiency
enhancements started in 2015 led to a significant improvement of
profitability. This was offset by negative price effects due to lower
raw material prices as well as partly negative impacts due to the
aggravated cooperation with the joint venture partner in Thailand.

Revenue of the Medical Sector decreased by 6.0% to EUR 85.9 million
in the first quarter of 2016 due to heavy price pressure and the
focus on high-margin customer relationships. EBITDA improved
significantly by 27.1% to EUR 6.1 million.

In summary, the Semperit Group generated earnings after tax amounting
to EUR 10.1 million (after EUR 12.6 million) in the first quarter of
2016. This decline compared with the same period of the previous year
was primarily due to negative foreign currency effects as well as
higher interest expenses.

Outlook 2016 In 2016, Semperit expects no significant changes of the
market conditions compared to 2015. The generally low demand in the
Industrial Sector in 2015 is expected to continue in 2016 due to the
economic situation. In particular in Eastern Europe and Russia, no
economic recovery is to be expected. Neither does the industrial
capital investment cycle show any signs of an upturn, especially in
China. However, demand in the economically insensitive Medical Sector
is expected to develop steadily with a market growth of 5% to 6%.

Nevertheless, Semperit looks at the year 2016 with a certain amount
of confidence and expects a largely stable development in 2016
compared to 2015. In the first months of 2016 Semperit has seen a
continuing good order situation due to intensive marketing and sales
activities in the Industrial Sector. The Medical Sector will profit
from the step-by-step commissioning of new production capacities in
Kamunting, Malaysia, in 2016 and beyond.

The Semperit Group will continue its growth strategy consistently in
2016. The focus will be on the entering into new markets in the
Industrial Sector and the expansion and optimisation of existing
production capacities. In the Medical Sector the focus will be set on
the expansion of the glove production in Malaysia in addition to
further production optimisations, efficiency enhancements and